Sumitomo Mitsui Trust Holdings, Inc. Axsome Therapeutics, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $164 Billion
- Q4 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,900 shares of AXSM stock, worth $265,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,900Holding current value
$265,411% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
422Shares Held
37MCall Options Held
752KPut Options Held
567K-
Vanguard Group Inc Valley Forge, PA4.18MShares$584 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$461 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.33MShares$186 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY1.12MShares$156 Million1.82% of portfolio
-
Macquarie Group LTD Australia, C31.08MShares$151 Million0.16% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...